NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ADNTRO GENETICS

ADNTRO GENETICS

Private
PalmaHealthcare & Life Scienceshttps://adntro.com/en/

Last Round

Seed

Oct 4, 2024

Total Funding Raised

$1.1M

Company Overview

ADNTRO GENETICS is a biotechnology company that provides direct-to-consumer DNA testing kits and bioinformatics analysis for insights into ancestry, health, nutrition, and sports performance.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, D2C Brands, Healthcare Analytics

Business Model

B2C

Customer Profile

Hardware + Subscription, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

genetic testingDNA analysispersonalized genomicsbioinformaticspolygenic risk scorePRSdirect-to-consumer DNADTC geneticspharmacogeneticsprecision medicinegenetic counselinggenomic dataAI health assistanthealth techbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ADNTRO GENETICS Comps

Public and private peers based on sector, stage, and business model.

ADNTRO GENETICS comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ADNTRO GENETICS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 4, 2024
AcceleratorDec 1, 2021
View all Funding Rounds

Key People

Founding team and executive leadership

Jorge Blom-Dahl Oliver

CTO And Cofounder

Founding Team

Guillermo Pérez-Solero Monzon

CEO Founder

Founding Team

ADNTRO GENETICS Investors

Notable investors and investment history

ADNTRO GENETICS investors
InvestorRounds
LanzaderaAccelerator, Seed
Noso CapitalSeed
Addendum CapitalSeed
Blue Goose CapitalSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2021

    Received funding from Lanzadera.

View all signals

ADNTRO GENETICS Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ADNTRO GENETICS Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ADNTRO GENETICS's valuation, stock price, and market status.

Firmographic Details

HeadquartersPalma
Employee Range17
Year Founded2019
Last FundingOct 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.